Pierre Ly

Villejuif, 94805, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.

Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.

Journal: Cancer cell

Published: September 01, 2025

Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.

Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.

Journal: Cancer discovery

Published: August 28, 2024

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.

Journal: Cancer cell

Published: January 27, 2024

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome.

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome.

Journal: Cell

Published: August 30, 2023

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.

Journal: Science (New York, N.Y.)

Published: June 08, 2023

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies.

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies.

Journal: Oncoimmunology

Published: January 12, 2023

BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.

BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.

Journal: Cancer discovery

Published: November 28, 2022

Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Journal: Cancer discovery

Published: February 18, 2022

Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer.

Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer.

Journal: Journal for immunotherapy of cancer

Published: January 08, 2022

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

Journal: Cancer discovery

Published: November 03, 2021

Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.

Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.

Journal: Cancer discovery

Published: July 25, 2021

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Journal: Cell death and differentiation

Published: January 30, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026